[Somatic disorders during long-term drug treatment of schizophrenic patients].
D000380:Agranulocytosis / Q000139:chemically induced; D001341:Autonomic Nervous System / Q000187:drug effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D004827:Epilepsy / Q000139:chemically induced; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008599:Menstruation Disturbances / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D009422:Nervous System Diseases / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D013923:Thromboembolism / Q000139:chemically induced; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects*
D014149:Tranquilizing Agents
Körperliche Störungen bei medikamentöser Langzeitbehandlung Schizophrener